webinar register page

Practical Applications of ctDNA Testing For Residual Disease and Recurrence
The Inivata RaDaR assay has industry leading sensitivity – why is this important?

• Using residual disease and recurrence assays opens new options for clinical trial design

• Data from a recent NSCLC clinical trial

Mar 17, 2021 04:00 PM in London

* Required information

By registering, I agree to the Privacy Statement and Terms of Service.